Public Education to Promote Family Communication and Well-being
Launched by THE UNIVERSITY OF HONG KONG · May 22, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SMART Family-Link Project is a clinical trial designed to explore how using technology can help families communicate better and improve their overall happiness and well-being. The study will focus on public education activities, such as community events and workshops, that encourage families to interact and share positive experiences. Researchers want to see how satisfied participants are with these activities, how effectively they are implemented, and how much they can positively impact family relationships.
To participate, individuals must be Chinese-speaking, at least 18 years old, and able to complete a questionnaire. The trial is currently recruiting participants of all genders aged 18 and older. Those who join can expect to take part in engaging activities while providing feedback through surveys and interviews. Observers will also monitor participation to gather valuable insights. This study aims to show how technology can enhance family connections and contribute to a happier community.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chinese-speaking
- • Aged 18 years and above
- • Able to complete the questionnaire
- Exclusion Criteria:
- • Subjects who fail to meet the inclusion criteria
About The University Of Hong Kong
The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Trial Officials
Tai-hing Lam, MD
Principal Investigator
The University of Hong Kong
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials